Farmaceutica (Romania) Performance
| RMAH Stock | 0.90 0.01 1.12% |
On a scale of 0 to 100, Farmaceutica holds a performance score of 21. The firm shows a Beta (market volatility) of 0.25, which means not very significant fluctuations relative to the market. As returns on the market increase, Farmaceutica's returns are expected to increase less than the market. However, during the bear market, the loss of holding Farmaceutica is expected to be smaller as well. Please check Farmaceutica's sortino ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to make a quick decision on whether Farmaceutica's price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Farmaceutica R are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Farmaceutica displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Farmaceutica |
Farmaceutica Relative Risk vs. Return Landscape
If you would invest 70.00 in Farmaceutica R on October 29, 2025 and sell it today you would earn a total of 20.00 from holding Farmaceutica R or generate 28.57% return on investment over 90 days. Farmaceutica R is generating 0.4639% of daily returns and assumes 1.706% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Farmaceutica, and 91% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Farmaceutica Target Price Odds to finish over Current Price
The tendency of Farmaceutica Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.90 | 90 days | 0.90 | near 1 |
Based on a normal probability distribution, the odds of Farmaceutica to move above the current price in 90 days from now is near 1 (This Farmaceutica R probability density function shows the probability of Farmaceutica Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Farmaceutica has a beta of 0.25 indicating as returns on the market go up, Farmaceutica average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Farmaceutica R will be expected to be much smaller as well. Additionally Farmaceutica R has an alpha of 0.3667, implying that it can generate a 0.37 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Farmaceutica Price Density |
| Price |
Predictive Modules for Farmaceutica
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Farmaceutica R. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Farmaceutica Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Farmaceutica is not an exception. The market had few large corrections towards the Farmaceutica's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Farmaceutica R, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Farmaceutica within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.37 | |
β | Beta against Dow Jones | 0.25 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | 0.19 |
Farmaceutica Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Farmaceutica for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Farmaceutica R can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Farmaceutica R has some characteristics of a very speculative penny stock |
About Farmaceutica Performance
By examining Farmaceutica's fundamental ratios, stakeholders can obtain critical insights into Farmaceutica's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Farmaceutica is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Farmaceutica R performance evaluation
Checking the ongoing alerts about Farmaceutica for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Farmaceutica R help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Farmaceutica R has some characteristics of a very speculative penny stock |
- Analyzing Farmaceutica's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Farmaceutica's stock is overvalued or undervalued compared to its peers.
- Examining Farmaceutica's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Farmaceutica's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Farmaceutica's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Farmaceutica's stock. These opinions can provide insight into Farmaceutica's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Farmaceutica Stock
Farmaceutica financial ratios help investors to determine whether Farmaceutica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Farmaceutica with respect to the benefits of owning Farmaceutica security.